Inactive Instrument

Calendar GENFIT Euronext Paris

Stocks

FR0004163111

Biotechnology & Medical Research

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

07-03	Genfit soars on news of U.S. reimbursement for a product
07-03	Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement	MT

Upcoming events on GENFIT

29/09/2026	Earnings release - Q2 2026
05/11/2026	Sales and Revenue Release - Q3 2026

Past events on GENFIT

15/06/2026	Présentation aux Actionnaires / Analystes	12:00
15/06/2026	Extraordinary General Meeting
15/06/2026	Annual General Meeting
21/05/2026	Sales and Revenue Release - Q1 2026
02/04/2026	Earnings release - Annual 2025
26/02/2026	Sales and Revenue Release - Annual 2025
20/11/2025	Sales and Revenue Release - Q3 2025
22/09/2025	Earnings release - Q2 2025

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million EUR	Released Forecast Spread	38,2 61,6 -38.07%	70,9 77,4 -8.31%	71,1 66,8 6.43%	100	124	147
EBITDA Million EUR	Released Forecast Spread	-24,9 -38,2 34.76%	5,01 29,4 -82.98%	-51,8 -41,3 -25.29%	28,1	60,7	72,1
EBIT Million EUR	Released Forecast Spread	-26,6 -25,4 -4.81%	3,28 16,8 -80.47%	-4,50 -5,35 15.87%	34,2	67,0	84,9
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	-28,5 5,23 -645.39%	1,85 2,70 -31.59%	-86,5 -5,35 -1515.44%	42,7	126	122
Net income Million EUR	Released Forecast Spread	-28,9 -21,9 -32.17%	1,51 20,1 -92.51%	-86,0 -8,30 -935.48%	22,9	6,80	33,3
EPS EUR	Released Forecast Spread	-0,58 -0,56 -3.66%	0,03 0,26 -88.24%	-1,72 -0,10 -1656.36%	0,39	0,15	1,10
Announcement Date		04/04/24	24/04/25	02/04/26	-

Quarterly results

Fiscal Period	December	2024 S1	2024 Q4	2024 S2	2025 Q1	2025 S1	2025 S2	2026 Q1	2026 S1	2026 S2
Net sales Million EUR	Released Forecast Spread	61,2 48,3 26.79%	11,2 7,30 53.96%	9,74 23,1 -57.77%	2,80 133 -97.89%	35,7 98,6 -63.81%	35,4 42,1 -15.81%	9,60 9,50 1.05%	33,4	40,8
EBIT Million EUR	Released Forecast Spread	31,2 21,1 48.11%		-27,9 -26,8 -4.26%		0,08 57,9 -99.87%	-4,50 4,40 -202.29%
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	30,3 22,8 32.93%		-28,5 -27,6 -3.27%		-10,1 57,8 -117.49%	-76,4 3,30 -2415.06%
Net income Million EUR	Released Forecast Spread	30,3 17,2 76.02%		-28,8 -11,5 -150.47%		-9,96 51,4 -119.37%	-76,0 0,85 -9042.59%		-0,80	5,30
EPS EUR	Released Forecast Spread	0,53 0,49 8.16%		-0,50 -0,55 9.09%		-0,20 2,18 -109.17%
Announcement Date		19/09/24	24/04/25	24/04/25	22/05/25	22/09/25	02/04/26	21/05/26	-	-

Upcoming sector events for GENFIT

Today	ICON PUBLIC LIMITED COMPANY	Annual General Meeting	14:00
Today	BOJI MEDICAL TECHNOLOGY CO.,LTD.	Extraordinary General Meeting	10:30
04/08/2026	STOKE THERAPEUTICS, INC.	Earnings release - Q2 2026
04/08/2026	STOKE THERAPEUTICS, INC.	Earnings presentation	00:30
05/08/2026	BEONE MEDICINES AG	Earnings presentation	16:00
05/08/2026	BEONE MEDICINES AG	Earnings release - Q2 2026
05/08/2026	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	Earnings presentation	17:00
05/08/2026	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	Earnings release - Q2 2026
05/08/2026	KYMERA THERAPEUTICS, INC.	Earnings presentation	16:30
05/08/2026	KYMERA THERAPEUTICS, INC.	Earnings release - Q2 2026

Past sector events for GENFIT

31/07/2026	TEMPUS AI, INC.	Earnings release - Q2 2026
31/07/2026	TEMPUS AI, INC.	Earnings presentation	00:30
30/07/2026	ICON PUBLIC LIMITED COMPANY	Earnings release - Q2 2026
30/07/2026	ICON PUBLIC LIMITED COMPANY	Earnings presentation	16:00
30/07/2026	BACHEM HOLDING AG	Earnings release - Q2 2026
30/07/2026	BACHEM HOLDING AG	Earnings presentation	12:00
30/07/2026	SYNGENE INTERNATIONAL LIMITED	Earnings presentation	07:30
29/07/2026	IONIS PHARMACEUTICALS, INC.	Earnings release - Q2 2026
29/07/2026	IONIS PHARMACEUTICALS, INC.	Earnings presentation	16:30
29/07/2026	FORTREA HOLDINGS INC.	Earnings presentation	16:00

As early as today, start finding the best investment opportunities!